| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 126.256 | 78 |
| GSM780708 | Untreated after 4 days (C2_1) | 108.789 | 76 |
| GSM780709 | Untreated after 4 days (C3_1) | 124.541 | 78 |
| GSM780719 | Untreated after 4 days (C1_2) | 153.116 | 81 |
| GSM780720 | Untreated after 4 days (C2_2) | 119.057 | 78 |
| GSM780721 | Untreated after 4 days (C3_2) | 128.99 | 79 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 104.363 | 76 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 94.3671 | 74 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 109.392 | 76 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 108.402 | 76 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 117.654 | 77 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 104.143 | 76 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 107.457 | 76 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 100.034 | 75 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 101.585 | 75 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 114.084 | 77 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 104.831 | 76 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 110 | 77 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 133.549 | 79 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 106.307 | 76 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 104.536 | 76 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 121.361 | 78 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 129.712 | 79 |